Current articles and info about your health

Thursday, 20th November 2008

   home     about     authors     news     books     xml feed     sitemap     privacy     contact us

There are 7 users online

add to favorites
 make home page


Addiction Issues
 Aging
 Allergies & Sinuses
 Alternative Medicine
 Beauty & Health
 Books & Reading
 Common Illnesses
 Community Service
 Diabetic Health
 Dieting
 Diseases
 Environmental Health
 Exercise and Fitness
 Health Education
 Health Industry
 Health Insurance
 Health Legal Issues
 Health Technology
 Healthcare Services
 Healthy Eating
 Medical Equipment & Products
 Men's Health
 Mental and Emotional Health
 Muscle & Back Pain
 Nutrition and Supplements
 Pediatrics
 Pet Health
 Physical Therapy & Massage
 Prevention Health
 Vision Health
 Weight Management
 Women's Health

Our Newsletter

Sign up for our free
Health-Informant.com Ezine
Get all the latest Health news delivered right to your mailbox.

First Name:

Your Email:



We will never rent, share or sell your name to anyone else... ever! We respect your privacy!
  Other Resources


For other sources of health news, tips, and information, visit our resources page

 

  Submit an Article


Would you like to have your article posted? Click Here
 

 
 

BioCrystal, Ltd., Commercializes Novel Cell Culture Technology
Added: 01/23/2006
 Type: Summary
 Viewed: 550 time(s)
 [ Not Rated Yet ]
How would you rate this article:    Bad Good   Go » 
BioCrystal, Ltd., Commercializes Novel Cell Culture Technology

BioCrystal's disposable cell culture tool, OptiCell, is fully developed - Manufacturing processes and associated production quality standards are in place - Third party collaborations have successfully demonstrated the versatility of OptiCell for use in a broad range of applications for which traditional disposable cell culture devices are not suited.

An article titled "Cell Culture Advances Enable Better Biology," in the January 1,2006 issue of Genetic Engineering News, raises issues associated with the need for better cell culture practices - processes that more closely model in vivo conditions, improved sterility, devices for material storage and transfer, and turnkey media-to-cell culture packaging. OptiCell addresses all of these needs.

OptiCell is comprised of a hermetically sealed sterile chamber formed by two gas-permeable, transparent membranes sealed onto a microtiter plate-size plastic frame. The film permits differential O2 and CO2 exchange between the atmosphere and the internal chamber space in a ratio that is optimal for proper maintenance of the aerobic metabolism of cells, and a balanced pH in the cell culture medium. OptiCell is accessible through integrated self-sealing ports that provide a sterile fluid path to the chamber interior.

OptiCell’s patented design and construction make it the ideal tool for cell culture and subsequent procedures including in situ microscopy, time lapse studies, in situ immunocytostaining, transfections, single-cell cloning, and shipping live cells – direct from incubator to mailer to incubator. Cells are in contact with media at all times, facilitating OptiCell’s use in automated cell culture practices. OptiCell offers the ability to separate and scale up a selected cell population in the same sterile environment. OptiCell is also well suited for continuous, laboratory-scale antibody production.

BioCrystal will collaborate with others in developing bioreagent-coupled OptiCell products that offer the means to simplify and streamline cell culture practices. BioCrystal will feature OptiCell at the AACR Meeting (Booth 1325) in Washington DC April 1-5.

About BioCrystal

Formed in 1996, BioCrystal brought together an interdisciplinary science group into a business structure committed to the development of novel products for applications in the life sciences and clinical medicine. BioCrystal has been awarded 40 patents in three technology areas: compounds and procedures for the diagnosis and treatment of cancer; cell culture practices and products (OptiCell®); and nanocrystalline fluorescent markers (BioPixels®) for intracellular detection and analysis. Invitrogen Corporation acquired the BioPixels Business Unit in 2005.
Article Pages:  1  



  Article Comments   Add Comment | View All (0)
    There are currently no comments for this article.


Advanced Search

Good Resources

Create a Happier Life

Diabetes Diet

High Protein, Low Cal Food


Affiliate With Us
 


All content © 2008 Webmaster, BioCrystal, Ltd., Commercializes Novel Cell Culture Technology :: Health-Informant.com.